AUL
ADPT icon

AlphaGrep UK Ltd’s Adaptive Biotechnologies ADPT Stock Holding History

AlphaGrep UK Ltd’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
+16,508
New +$263K 0.07% 653

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AlphaGrep UK Ltd's ADPT Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Adaptive Biotechnologies (ADPT) in Q1 2026: 16,508 shares worth $229K. The stake represents 0.07% of the portfolio and ranks #653 among its holdings.

297 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • AlphaGrep UK Ltd held 16,508 shares of Adaptive Biotechnologies worth $229K as of Q1 2026.
  • Adaptive Biotechnologies was a new AlphaGrep UK Ltd position in Q1 2026.
  • Adaptive Biotechnologies made up 0.07% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #653 holding.
  • 297 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.